Zai Lab grants 2,000 ADS options and 84,893 ADS RSUs under 2024 plan

Bulletin Express07-03

Hong Kong, 3 July 2026—Zai Lab Limited announced the first awards under its 2024 Equity Incentive Plan, comprising both share options and restricted share units (RSUs) granted on 2 July 2026 (U.S. Eastern Time).

A single employee received 2,000 American depositary share (ADS) options—equivalent to 20,000 ordinary shares—at an exercise price of US$19.12 per ADS (about HK$14.91 per share). The options carry a ten-year term and vest in four equal annual tranches, contingent on continued employment.

The RSU component totals 84,893 ADSs (848,930 ordinary shares). Of these, 80,393 ADSs were awarded to Chairperson and CEO Dr. Samantha Du, while 4,500 ADSs were distributed among three other employees. RSUs require no purchase price and vest 25% annually over four years, also subject to continued service.

All awards were issued at the ADS closing price of US$19.12 (HK$14.99 per share on the Hong Kong market) recorded on the grant date. No performance targets or claw-back provisions apply, a structure the Board’s Compensation Committee considers consistent with market practice and the plan’s objectives.

Following the transaction, 59.42 million ordinary shares remain available for future grants under the scheme mandate limit of the 2024 Equity Incentive Plan.

The independent directors approved the RSU grant to Dr. Du, and the awards comply with Hong Kong Listing Rules limits on individual and aggregate equity issuances. No financial assistance is being provided to recipients for share purchases.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171941253?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171941253","market":"us","top_or_hot":-1,"title":"Zai Lab grants 2,000 ADS options and 84,893 ADS RSUs under 2024 plan","media":"Bulletin Express","content":"<p>Hong Kong, 3 July 2026—Zai Lab Limited announced the first awards under its 2024 Equity Incentive Plan, comprising both share options and restricted share units (RSUs) granted on 2 July 2026 (U.S. Eastern Time).</p>\n<p>A single employee received 2,000 American depositary share (ADS) options—equivalent to 20,000 ordinary shares—at an exercise price of US$19.12 per ADS (about HK$14.91 per share). The options carry a ten-year term and vest in four equal annual tranches, contingent on continued employment.</p>\n<p>The RSU component totals 84,893 ADSs (848,930 ordinary shares). Of these, 80,393 ADSs were awarded to Chairperson and CEO Dr. Samantha Du, while 4,500 ADSs were distributed among three other employees. RSUs require no purchase price and vest 25% annually over four years, also subject to continued service.</p>\n<p>All awards were issued at the ADS closing price of US$19.12 (HK$14.99 per share on the Hong Kong market) recorded on the grant date. No performance targets or claw-back provisions apply, a structure the Board’s Compensation Committee considers consistent with market practice and the plan’s objectives.</p>\n<p>Following the transaction, 59.42 million ordinary shares remain available for future grants under the scheme mandate limit of the 2024 Equity Incentive Plan.</p>\n<p>The independent directors approved the RSU grant to Dr. Du, and the awards comply with Hong Kong Listing Rules limits on individual and aggregate equity issuances. No financial assistance is being provided to recipients for share purchases.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zai Lab grants 2,000 ADS options and 84,893 ADS RSUs under 2024 plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZai Lab grants 2,000 ADS options and 84,893 ADS RSUs under 2024 plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-03 16:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong, 3 July 2026—Zai Lab Limited announced the first awards under its 2024 Equity Incentive Plan, comprising both share options and restricted share units (RSUs) granted on 2 July 2026 (U.S. Eastern Time).</p>\n<p>A single employee received 2,000 American depositary share (ADS) options—equivalent to 20,000 ordinary shares—at an exercise price of US$19.12 per ADS (about HK$14.91 per share). The options carry a ten-year term and vest in four equal annual tranches, contingent on continued employment.</p>\n<p>The RSU component totals 84,893 ADSs (848,930 ordinary shares). Of these, 80,393 ADSs were awarded to Chairperson and CEO Dr. Samantha Du, while 4,500 ADSs were distributed among three other employees. RSUs require no purchase price and vest 25% annually over four years, also subject to continued service.</p>\n<p>All awards were issued at the ADS closing price of US$19.12 (HK$14.99 per share on the Hong Kong market) recorded on the grant date. No performance targets or claw-back provisions apply, a structure the Board’s Compensation Committee considers consistent with market practice and the plan’s objectives.</p>\n<p>Following the transaction, 59.42 million ordinary shares remain available for future grants under the scheme mandate limit of the 2024 Equity Incentive Plan.</p>\n<p>The independent directors approved the RSU grant to Dr. Du, and the awards comply with Hong Kong Listing Rules limits on individual and aggregate equity issuances. No financial assistance is being provided to recipients for share purchases.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09688","symbol_name":"再鼎医药","start_time":0,"source_url":"","article_id":"1171941253","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171941253","pubTimestamp":1783068130,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong, 3 July 2026—Zai Lab Limited announced the first awards under its 2024 Equity Incentive Plan, comprising both share options and restricted share units (RSUs) granted on 2 July 2026 (U.S....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09688":"再鼎医药"},"translate_title":"再鼎医药根据2024年计划授予2,000份ADS期权和84,893份ADS RSU","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1},"content_text":"Hong Kong, 3 July 2026—Zai Lab Limited announced the first awards under its 2024 Equity Incentive Plan, comprising both share options and restricted share units (RSUs) granted on 2 July 2026 (U.S. Eastern Time).\nA single employee received 2,000 American depositary share (ADS) options—equivalent to 20,000 ordinary shares—at an exercise price of US$19.12 per ADS (about HK$14.91 per share). The options carry a ten-year term and vest in four equal annual tranches, contingent on continued employment.\nThe RSU component totals 84,893 ADSs (848,930 ordinary shares). Of these, 80,393 ADSs were awarded to Chairperson and CEO Dr. Samantha Du, while 4,500 ADSs were distributed among three other employees. RSUs require no purchase price and vest 25% annually over four years, also subject to continued service.\nAll awards were issued at the ADS closing price of US$19.12 (HK$14.99 per share on the Hong Kong market) recorded on the grant date. No performance targets or claw-back provisions apply, a structure the Board’s Compensation Committee considers consistent with market practice and the plan’s objectives.\nFollowing the transaction, 59.42 million ordinary shares remain available for future grants under the scheme mandate limit of the 2024 Equity Incentive Plan.\nThe independent directors approved the RSU grant to Dr. Du, and the awards comply with Hong Kong Listing Rules limits on individual and aggregate equity issuances. No financial assistance is being provided to recipients for share purchases.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171941253","isCrawlerRequest":true}